X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - ZACKS.COM - All Stories - 11/07/2024 13:02

United Therapeutics (UTHR) Completes Enrolment in IPF Study

United Therapeutics' (UTHR) late-stage study is evaluating Tyvaso inhalation solution in IPF patients living outside the United States and Canada.

Articles similaires

Sorry! Image not available at this time

Merck Announces Late-Breaking Data from Three Phase 3 Trials Evaluating Doravirine/Islatravir (DOR/ISL), an Investigational, Once-Daily, Two-Drug Regimen for the Treatment of Adults Living with HIV-1 at CROI 2026

drugs.com - 25/Feb 02:02

RAHWAY, N.J.--(BUSINESS WIRE)-- February 25, 2026 -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the...

Sorry! Image not available at this time

Merck Announces Late-Breaking Data from Three Phase 3 Trials Evaluating Doravirine/Islatravir (DOR/ISL), an Investigational, Once-Daily, Two-Drug Regimen for the Treatment of Adults Living with HIV-1 at CROI 2026

drugs.com - 25/Feb 02:02

RAHWAY, N.J.--(BUSINESS WIRE)-- February 25, 2026 -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the...

Sorry! Image not available at this time

Neurizon Initiates Dosing of NUZ-001 in HEALEY ALS Platform Trial

wn.com - 07:48

Neurizon Initiates Dosing of NUZ-001 in HEALEY ALS Platform Trial Highlights: First participant enrolled and dosed with NUZ-001 in Regimen I of the...

Sorry! Image not available at this time

Neurizon Initiates Dosing of NUZ-001 in HEALEY ALS Platform Trial

wn.com - 07:48

Neurizon Initiates Dosing of NUZ-001 in HEALEY ALS Platform Trial Highlights: First participant enrolled and dosed with NUZ-001 in Regimen I of the...

Sorry! Image not available at this time

Compared to Estimates, United Therapeutics (UTHR) Q4 Earnings: A Look at Key Metrics

zacks.com - 25/Feb 17:30

The headline numbers for United Therapeutics (UTHR) give insight into how the company performed in the quarter ended December 2025, but it may be...

Sorry! Image not available at this time

Compared to Estimates, United Therapeutics (UTHR) Q4 Earnings: A Look at Key Metrics

zacks.com - 25/Feb 17:30

The headline numbers for United Therapeutics (UTHR) give insight into how the company performed in the quarter ended December 2025, but it may be...

Sorry! Image not available at this time

United Therapeutics (UTHR) Surpasses Q4 Earnings Estimates

zacks.com - 25/Feb 17:15

United Therapeutics (UTHR) delivered earnings and revenue surprises of +13.50% and -1.88%, respectively, for the quarter ended December 2025. Do the...

Sorry! Image not available at this time

United Therapeutics (UTHR) Surpasses Q4 Earnings Estimates

zacks.com - 25/Feb 17:15

United Therapeutics (UTHR) delivered earnings and revenue surprises of +13.50% and -1.88%, respectively, for the quarter ended December 2025. Do the...

Sorry! Image not available at this time

Unveiling United Therapeutics (UTHR) Q4 Outlook: Wall Street Estimates for Key Metrics

zacks.com - 20/Feb 14:15

Get a deeper insight into the potential performance of United Therapeutics (UTHR) for the quarter ended December 2025 by going beyond Wall Street's...

Sorry! Image not available at this time

Unveiling United Therapeutics (UTHR) Q4 Outlook: Wall Street Estimates for Key Metrics

zacks.com - 20/Feb 14:15

Get a deeper insight into the potential performance of United Therapeutics (UTHR) for the quarter ended December 2025 by going beyond Wall Street's...

Les derniers communiqués